OCULUS has joined the International Myopia Institute (IMI) in tackling myopia awareness and will support the IMI activities to advance the research of myopia to prevent future vision impairment and blindness.

Christian Kirchhübel, CEO of OCULUS announces: “We are delighted about the cooperation. Our mission at OCULUS is to support eye care professionals around the world with cutting-edge, high-tech development. We are dedicated to saving and improving vision and visual performance with our precise, reliable long-lasting measurement solutions.”

The IMI is a global group of experts who have come together to discuss, debate and make available the latest evidence-based recommendations in classifications, patient management, and research, in the form of the IMI white papers, in up to twelve international languages.

Prof. Michael Belin summarizes the different features of the Pentacam® supporting the physician in the interpretation of the displays and their clinical use.

It ranges from the 4 Maps Refractive over the Belin/Ambrósio Enhanced Ectasia Display to the Belin ABCD Staging and Progression Display including the objective assessment after the CXL treatment.

More information can be found on the website of “The Journal of Cornea and External Disease”